Use of capecitabine to prevent acute renal allograft rejection in dog erythrocyte antigen-mismatched mongrel dogs.

TitleUse of capecitabine to prevent acute renal allograft rejection in dog erythrocyte antigen-mismatched mongrel dogs.
Publication TypeJournal Article
Year of Publication2007
AuthorsMilovancev M, Schmiedt CW, Bentley E, Schwab M, Dubielzig RR, Gendron-Fitzpatrick AP, McAnulty JF
JournalVeterinary surgery : VS
Volume36
Issue1
Pagination10-20
Date Published2007 Jan
ISSN0161-3499
KeywordsAdministration, Oral, Animals, Antimetabolites, Antineoplastic, Blood Cell Count, Cyclosporine, Deoxycytidine, Dogs, Dose-Response Relationship, Drug, Dose-Response Relationship, Immunologic, Drug Therapy, Combination, Female, Fluorouracil, Graft Rejection, Immunosuppressive Agents, Kidney Transplantation, Nephrectomy, Pilot Projects, Postoperative Complications, Prospective Studies, Survival Analysis, Transplantation, Homologous, Treatment Outcome
Abstract

To assess efficacy and toxicity of a capecitabine (CAP)-based regimen for preventing rejection of renal allografts in dog erythrocyte antigen (DEA)-mismatched mongrel dogs.

Alternate JournalVet Surg
Tags: